StockData
PETVOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31

PetVivo Holdings, Inc.

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.75+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$27.79M
P/E (TTM)
–
Dividend yield
–

PetVivo Holdings, Inc. revenue by segment

By business segment

By product or service

RevenueQ1 27Q4 26Q3 26Q2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24% of revenueYoY
Sales to Vedco [Member]$234.62K$166.32K$216.97K$227.50K$198.38K$0$129.70K$0$0–––69.5%+18.3%
Clipper [Member]$40.52K–––$0–––––––12.0%–
Product [Member]–$0$0$0$0$8.45K$202.74K$177.84K$50.68K$16.88K$439.92K$151.16K––
Sales to Convetrus [Member]–$0$0$0$0$8.80K$17.61K$0$17.78K–$106.70K$0––
Sales To Clipper [Member]–$24.31K$16.21K––$0$194.50K–––––––

By region

From the segment and revenue-disaggregation notes of PetVivo's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.